Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease

This review describes targeting neutrophils as a potential therapeutic strategy for acute respiratory distress syndrome (ARDS) associated with coronavirus disease 2019 (COVID-19), a pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Neutrophil counts are significantly e...

Full description

Bibliographic Details
Main Authors: Chih-Chao Chiang, Michal Korinek, Wei-Jen Cheng, Tsong-Long Hwang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.572009/full
_version_ 1819205626781237248
author Chih-Chao Chiang
Chih-Chao Chiang
Michal Korinek
Michal Korinek
Michal Korinek
Wei-Jen Cheng
Wei-Jen Cheng
Wei-Jen Cheng
Tsong-Long Hwang
Tsong-Long Hwang
Tsong-Long Hwang
Tsong-Long Hwang
Tsong-Long Hwang
author_facet Chih-Chao Chiang
Chih-Chao Chiang
Michal Korinek
Michal Korinek
Michal Korinek
Wei-Jen Cheng
Wei-Jen Cheng
Wei-Jen Cheng
Tsong-Long Hwang
Tsong-Long Hwang
Tsong-Long Hwang
Tsong-Long Hwang
Tsong-Long Hwang
author_sort Chih-Chao Chiang
collection DOAJ
description This review describes targeting neutrophils as a potential therapeutic strategy for acute respiratory distress syndrome (ARDS) associated with coronavirus disease 2019 (COVID-19), a pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Neutrophil counts are significantly elevated in patients with COVID-19 and significantly correlated with disease severity. The neutrophil-to-lymphocyte ratio can serve as a clinical marker for predicting fatal complications related to ARDS in patients with COVID-19. Neutrophil-associated inflammation plays a critical pathogenic role in ARDS. The effector functions of neutrophils, acting as respiratory burst oxidants, granule proteases, and neutrophil extracellular traps, are linked to the pathogenesis of ARDS. Hence, neutrophils can not only be used as pathogenic markers but also as candidate drug targets for COVID-19 associated ARDS.
first_indexed 2024-12-23T04:54:42Z
format Article
id doaj.art-b3b8486b388348bb8ce82bfb64432ef5
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-23T04:54:42Z
publishDate 2020-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-b3b8486b388348bb8ce82bfb64432ef52022-12-21T17:59:22ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-10-011110.3389/fphar.2020.572009572009Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus DiseaseChih-Chao Chiang0Chih-Chao Chiang1Michal Korinek2Michal Korinek3Michal Korinek4Wei-Jen Cheng5Wei-Jen Cheng6Wei-Jen Cheng7Tsong-Long Hwang8Tsong-Long Hwang9Tsong-Long Hwang10Tsong-Long Hwang11Tsong-Long Hwang12Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, TaiwanPuxin Fengze Chinese Medicine Clinic, Taoyuan, TaiwanGraduate Institute of Natural Products, College of Medicine, Chang Gung University, Taoyuan, TaiwanResearch Center for Chinese Herbal Medicine, Research Center for Food and Cosmetic Safety, and Graduate Institute of Health Industry Technology, Chang Gung University of Science and Technology, Taoyuan, TaiwanDepartment of Biotechnology, College of Life Science, Kaohsiung Medical University, Kaohsiung, TaiwanGraduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, TaiwanSchool of Traditional Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan, TaiwanCenter for Traditional Chinese Medicine, Chang Gung Memorial Hospital, Taoyuan, TaiwanGraduate Institute of Natural Products, College of Medicine, Chang Gung University, Taoyuan, TaiwanResearch Center for Chinese Herbal Medicine, Research Center for Food and Cosmetic Safety, and Graduate Institute of Health Industry Technology, Chang Gung University of Science and Technology, Taoyuan, TaiwanSchool of Traditional Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan, TaiwanDepartment of Anesthesiology, Chang Gung Memorial Hospital, Taoyuan, TaiwanDepartment of Chemical Engineering, Ming Chi University of Technology, New Taipei City, TaiwanThis review describes targeting neutrophils as a potential therapeutic strategy for acute respiratory distress syndrome (ARDS) associated with coronavirus disease 2019 (COVID-19), a pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Neutrophil counts are significantly elevated in patients with COVID-19 and significantly correlated with disease severity. The neutrophil-to-lymphocyte ratio can serve as a clinical marker for predicting fatal complications related to ARDS in patients with COVID-19. Neutrophil-associated inflammation plays a critical pathogenic role in ARDS. The effector functions of neutrophils, acting as respiratory burst oxidants, granule proteases, and neutrophil extracellular traps, are linked to the pathogenesis of ARDS. Hence, neutrophils can not only be used as pathogenic markers but also as candidate drug targets for COVID-19 associated ARDS.https://www.frontiersin.org/article/10.3389/fphar.2020.572009/fullcoronavirus disease 2019severe acute respiratory syndrome coronavirus 2acute respiratory distress syndromeneutrophilsneutrophil extracellular trap
spellingShingle Chih-Chao Chiang
Chih-Chao Chiang
Michal Korinek
Michal Korinek
Michal Korinek
Wei-Jen Cheng
Wei-Jen Cheng
Wei-Jen Cheng
Tsong-Long Hwang
Tsong-Long Hwang
Tsong-Long Hwang
Tsong-Long Hwang
Tsong-Long Hwang
Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease
Frontiers in Pharmacology
coronavirus disease 2019
severe acute respiratory syndrome coronavirus 2
acute respiratory distress syndrome
neutrophils
neutrophil extracellular trap
title Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease
title_full Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease
title_fullStr Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease
title_full_unstemmed Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease
title_short Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease
title_sort targeting neutrophils to treat acute respiratory distress syndrome in coronavirus disease
topic coronavirus disease 2019
severe acute respiratory syndrome coronavirus 2
acute respiratory distress syndrome
neutrophils
neutrophil extracellular trap
url https://www.frontiersin.org/article/10.3389/fphar.2020.572009/full
work_keys_str_mv AT chihchaochiang targetingneutrophilstotreatacuterespiratorydistresssyndromeincoronavirusdisease
AT chihchaochiang targetingneutrophilstotreatacuterespiratorydistresssyndromeincoronavirusdisease
AT michalkorinek targetingneutrophilstotreatacuterespiratorydistresssyndromeincoronavirusdisease
AT michalkorinek targetingneutrophilstotreatacuterespiratorydistresssyndromeincoronavirusdisease
AT michalkorinek targetingneutrophilstotreatacuterespiratorydistresssyndromeincoronavirusdisease
AT weijencheng targetingneutrophilstotreatacuterespiratorydistresssyndromeincoronavirusdisease
AT weijencheng targetingneutrophilstotreatacuterespiratorydistresssyndromeincoronavirusdisease
AT weijencheng targetingneutrophilstotreatacuterespiratorydistresssyndromeincoronavirusdisease
AT tsonglonghwang targetingneutrophilstotreatacuterespiratorydistresssyndromeincoronavirusdisease
AT tsonglonghwang targetingneutrophilstotreatacuterespiratorydistresssyndromeincoronavirusdisease
AT tsonglonghwang targetingneutrophilstotreatacuterespiratorydistresssyndromeincoronavirusdisease
AT tsonglonghwang targetingneutrophilstotreatacuterespiratorydistresssyndromeincoronavirusdisease
AT tsonglonghwang targetingneutrophilstotreatacuterespiratorydistresssyndromeincoronavirusdisease